These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10440605)

  • 1. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study.
    Meineche-Schmidt V; Talley NJ; Pap A; Kordecki H; Schmid V; Ohlsson L; Wahlqvist P; Wiklund I; Bolling-Sternevald E
    Scand J Gastroenterol; 1999 Jun; 34(6):566-74. PubMed ID: 10440605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
    Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
    Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
    Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
    Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
    Färkkilä M; Sarna S; Valtonen V; Sipponen P;
    Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
    Farup PG; Hovde O; Torp R; Wetterhus S
    Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting.
    Laheij RJ; Hermsen JT; Jansen JB; Horrevorts AM; Rongen RJ; Van Rossum LG; Witteman E; de Koning RW
    Fam Pract; 2004 Jun; 21(3):238-43. PubMed ID: 15128682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE; Sander GB; Francesconi CF; Mazzoleni F; Uchoa DM; De Bona LR; Milbradt TC; Von Reisswitz PS; Berwanger O; Bressel M; Edelweiss MI; Marini SS; Molina CG; Folador L; Lunkes RP; Heck R; Birkhan OA; Spindler BM; Katz N; Colombo Bda S; Guerrieri PP; Renck LB; Grando E; Hocevar de Moura B; Dahmer FD; Rauber J; Prolla JC
    Arch Intern Med; 2011 Nov; 171(21):1929-36. PubMed ID: 22123802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
    Moayyedi P; Feltbower R; Brown J; Mason S; Mason J; Nathan J; Richards ID; Dowell AC; Axon AT
    Lancet; 2000 May; 355(9216):1665-9. PubMed ID: 10905240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.
    Madsen LG; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):365-72. PubMed ID: 15274674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N; Van Zanten SJ; Sinclair P; Ferguson RA; Escobedo S; Grace E
    BMJ; 2002 Apr; 324(7344):1012-6. PubMed ID: 11976244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption.
    Meineche-Schmidt V
    Am J Gastroenterol; 2004 Jun; 99(6):1050-8. PubMed ID: 15180724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment.
    Manes G; Menchise A; de Nucci C; Balzano A
    BMJ; 2003 May; 326(7399):1118. PubMed ID: 12763982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.